GeneNews' Q4 Revenues Increase on Milestone Revenue

GeneNews' revenues for the quarter and year came primarily from a biomarker research pact with an Asian biomedical consortium. The firm's primary efforts center on launching and selling its ColonSentry test.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories